Industry News
Antisense offers key to new MS treatment
A new way to treat multiple sclerosis (MS) with antisense drugs is being developed by Melbourne company Antisense Therapeutics with the assistance of its US partner Isis Pharmaceuticals. [ + ]
Eye researcher wins award
Dedication to warding off a common form of blindness has earned a Melbourne ophthalmologist the 2002 Amgen Medical Researcher Award. [ + ]
HPLC market report: Cents and sensitivity
Ease of use, reliability and service and support are the main things that scientists consider when buying a new chromatography system. But previous familiarity with a particular brand is also a major factor. [ + ]
HPLC market report: The smaller picture
The big trend in liquid chromatography instrumentation is the ever-shrinking sample size, according to leading manufacturers of chromatographic instruments. [ + ]
Billionare buys Amrad stake
In a much-needed show of investor support, cardboard king Richard Pratt has become a substantial shareholder of Amrad Corporation. [ + ]
GroPep restructures, outlines new directions
Adelaide growth factor biobusiness GroPep has laid out its path to profits by announcing plans to concentrate on growing its pharmaceutical cell culture division. [ + ]
Academy awards and grants - nominations open
Nominations are now open for the Australian Academy of Science's Awards for Scientific Excellence and Grants for International Travel.
[ + ]Greenpeace launches GE shopping guide
Australian cookbook icon Margaret Fulton joined Greenpeace at Sydney's Fox Studios on Friday last week to launch the environmental campaigner's True Food Guide book. [ + ]
Now we're a global player: stem cell CEO
Australia's decision to back stem cell research with a $46.5 million grant would have international ramifications for local researchers, according to the head of the winning Centre of Excellence bid. [ + ]
Proteome Systems launches ProteomIQ, moves into Japan
Sydney-based company Proteome Systems' proteomics R&D system, ProteomIQ, has been launched on the market. [ + ]
New Zealand joins synchrotron project
A New Zealand representative is to join the Australian Synchrotron Project's scientific advisory committee, cementing a trans-Tasman link between users of the new facility. [ + ]
Trans-Tasman biotech collaborations sought
New Zealand's political leadership is declaring the Land of the Long White Cloud open for collaborative ventures with Australia's biotech sector. [ + ]
CEO, directors depart as Bio21 changes direction
The chief executive officer and three other directors have resigned from Bio21 following a restructure that has seen the company abandon its commercial focus. [ + ]
WEHI research suggests alternative MS treatment
Researchers at the Walter and Eliza Hall Institute have discovered that treatment with cytokine Leukaemia Inhibitory Factor (LIF) can reverse the loss of nerve cells in a mouse model of multiple sclerosis (MS). [ + ]
Australian microarray meeting - South Stradbroke Island
The 2nd Australian Microarray Meeting is to be held at Couran Cove Resort, Sth Stradbroke Island from July 24th to 26th 2002. The meeting will focus on show casing recent national and international advances in expression profiling and other microarray technologies.
[ + ]